Latest news
Loading news…
Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.
Concert Pharmaceuticals was acquired by Sun Pharmaceutical in 2023 for $576M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
66
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Lexington, Massachusetts, United States
Key People at Concert Pharmaceuticals
Founder, President, CEO & Board of Directors
VP Drug Development
66
professional contacts at Concert Pharmaceuticals
Contact execs at Concert Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Concert Pharmaceuticals
Loading news…
FAQs about Concert Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.